Exact FDA event identifier

Event 90539

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: June 27, 2022
Product types: Drug
Classifications: Class I
Statuses: Terminated
Recalling firm wording: Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Nifedipine WSP 0.2% Ointment, 60 gram tubes, Rx only, Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704

D-1286-2022

Recall number: D-1286-2022
Initiated: June 27, 2022
Classification: Class I
Status: Terminated
Recalling firm: Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy
Quantity: 5 (60 gram) tubes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0

Subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Subpotent and Superpotent Drug

Code information

Lot #: 06162022@30, BUD 12/13/2022

Distribution pattern

CA only